← All organizations
Highest phase reached
Phase 3
First clinical trial
Nov 2, 1999Last known activity
Apr 30, 2024
Timeline
1910s
- Jan 1, 1917
Ajinomoto— Founded
2000s
- Jun 1, 2009
Altus Pharmaceuticals— Acquired
2010s
- Nov 10, 2017
Cambrooke Therapeutics— Acquired
2020s
- Nov 14, 2023
Forge Biologics, Inc— Acquired
Drugs by trial phase (17 distinct, 24 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (3 own, 2 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (8 own, 0 via acquisition)
Indications
Subsidiaries (3 direct, 3 total across the full acquisition tree)
Recent trials (23)
- NCT06387186CollaboratorPhase 1Apr 30, 2024
- NCT06387186CollaboratorPhase 1Apr 30, 2024
- NCT02859181CollaboratorN/AJul 1, 2017
- NCT03163043CollaboratorN/AOct 22, 2016
- NCT02874638CollaboratorN/ASep 1, 2016
- NCT02800239CollaboratorN/AFeb 1, 2016
- NCT02626429CollaboratorN/AMay 1, 2015
- NCT02478814CollaboratorEarly Phase 1Apr 1, 2015
- NCT02343497Lead sponsorN/AAug 1, 2014
- NCT01890369CollaboratorN/AApr 1, 2013
- NCT02616913CollaboratorN/AMar 31, 2013
- NCT02446106Lead sponsorN/AJun 1, 2012
- NCT01761045Lead sponsorN/AJul 1, 2010
- NCT01215396CollaboratorPhase 1Jul 1, 2010
- NCT00692601Study chairPhase 1Apr 1, 2008
Details
- Founded
- Tokyo, JP Jan 1, 1917
- Last known activity
- Apr 30, 2024